Moreover, a 50% survival rate was reported for rats treated with the chymase inhibitor beginning 8 weeks after the start of HFC diet feeding, at which point NASH was established (Miyaoka et al., 2017). This evidence concerns the gene CMA1 and metabolic dysfunction-associated steatohepatitis.